{"id":"https://openalex.org/W2092016452","doi":"https://doi.org/10.1002/hup.1050","title":"Neuropsychological functioning in buprenorphine maintained patients versus abstinent heroin abusers on naltrexone hydrochloride therapy","display_name":"Neuropsychological functioning in buprenorphine maintained patients versus abstinent heroin abusers on naltrexone hydrochloride therapy","publication_year":2009,"publication_date":"2009-08-03","ids":{"openalex":"https://openalex.org/W2092016452","doi":"https://doi.org/10.1002/hup.1050","mag":"2092016452","pmid":"https://pubmed.ncbi.nlm.nih.gov/19650155"},"language":"en","primary_location":{"id":"doi:10.1002/hup.1050","doi":"https://doi.org/10.1002/hup.1050","is_oa":false,"landing_page_url":"https://doi.org/10.1002/hup.1050","pdf_url":null,"source":{"id":"https://openalex.org/S154207414","display_name":"Human Psychopharmacology Clinical and Experimental","issn_l":"0885-6222","issn":["0885-6222","1099-1077"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Psychopharmacology: Clinical and Experimental","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://doi.org/10.1002/hup.1050","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066152346","display_name":"Lambros Messinis","orcid":"https://orcid.org/0000-0002-3216-9025","observed_orcids":["https://orcid.org/0000-0002-3216-9025"]},"institutions":[{"id":"https://openalex.org/I174878644","display_name":"University of Patras","ror":"https://ror.org/017wvtq80","country_code":"GR","type":"education","lineage":["https://openalex.org/I174878644"]}],"countries":["GR"],"is_corresponding":true,"raw_author_name":"Lambros Messinis","raw_affiliation_strings":["Department of Neurology, Neuropsychology Section, University of Patras Medical School, Greece. lmessinis@upatras.gr","Department of Neurology, Neuropsychology Section, University of Patras Medical School, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Neuropsychology Section, University of Patras Medical School, Greece. lmessinis@upatras.gr","institution_ids":["https://openalex.org/I174878644"]},{"raw_affiliation_string":"Department of Neurology, Neuropsychology Section, University of Patras Medical School, Greece","institution_ids":["https://openalex.org/I174878644"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083600817","display_name":"Epameinondas Lyros","orcid":"https://orcid.org/0000-0003-4225-3041","observed_orcids":["https://orcid.org/0000-0003-4225-3041"]},"institutions":[{"id":"https://openalex.org/I174878644","display_name":"University of Patras","ror":"https://ror.org/017wvtq80","country_code":"GR","type":"education","lineage":["https://openalex.org/I174878644"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Epameinondas Lyros","raw_affiliation_strings":["Department of Neurology, Neuropsychology Section, University of Patras Medical School, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Neuropsychology Section, University of Patras Medical School, Greece","institution_ids":["https://openalex.org/I174878644"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075035680","display_name":"V. Andrian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405271210","display_name":"Organisation Against Drugs","ror":"https://ror.org/0223a3n11","country_code":"GR","type":"government","lineage":["https://openalex.org/I4405271210"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Virginia Andrian","raw_affiliation_strings":["OKANA detoxification Unit Patras, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OKANA detoxification Unit Patras, Greece","institution_ids":["https://openalex.org/I4405271210"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038603392","display_name":"Paraskevi F. Katsakiori","orcid":"https://orcid.org/0009-0001-1640-1058","observed_orcids":["https://orcid.org/0009-0001-1640-1058"]},"institutions":[{"id":"https://openalex.org/I4405271210","display_name":"Organisation Against Drugs","ror":"https://ror.org/0223a3n11","country_code":"GR","type":"government","lineage":["https://openalex.org/I4405271210"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Paraskevi Katsakiori","raw_affiliation_strings":["OKANA detoxification Unit Patras, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OKANA detoxification Unit Patras, Greece","institution_ids":["https://openalex.org/I4405271210"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026542280","display_name":"George Panagis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142617266","display_name":"University of Crete","ror":"https://ror.org/00dr28g20","country_code":"GR","type":"education","lineage":["https://openalex.org/I142617266"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"George Panagis","raw_affiliation_strings":["Department of Psychology, Laboratory of Behavioral Neuroscience, University of Crete, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychology, Laboratory of Behavioral Neuroscience, University of Crete, Greece","institution_ids":["https://openalex.org/I142617266"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036271619","display_name":"Vasileios L. Georgiou","orcid":"https://orcid.org/0000-0002-5306-2796","observed_orcids":["https://orcid.org/0000-0002-5306-2796"]},"institutions":[{"id":"https://openalex.org/I102516824","display_name":"Universit\u00e9 de Technologie de Compi\u00e8gne","ror":"https://ror.org/04y5kwa70","country_code":"FR","type":"education","lineage":["https://openalex.org/I102516824"]},{"id":"https://openalex.org/I4210088387","display_name":"Heuristics and Diagnostics for Complex Systems","ror":"https://ror.org/0075hvk77","country_code":"FR","type":"facility","lineage":["https://openalex.org/I102516824","https://openalex.org/I1294671590","https://openalex.org/I4210088387","https://openalex.org/I4210159245"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Vasileios Georgiou","raw_affiliation_strings":["Heudiasy, Universite\u0301 Technologie de Campie\u0301gne, Campie\u0301gne, France","Heudiasy, Universit\u00e9 Technologie de Campi\u00e9gne, Campi\u00e9gne, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Heudiasy, Universite\u0301 Technologie de Campie\u0301gne, Campie\u0301gne, France","institution_ids":["https://openalex.org/I102516824","https://openalex.org/I4210088387"]},{"raw_affiliation_string":"Heudiasy, Universit\u00e9 Technologie de Campi\u00e9gne, Campi\u00e9gne, France","institution_ids":["https://openalex.org/I102516824"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058863233","display_name":"Panagiotis Papathanasopoulos","orcid":"https://orcid.org/0000-0002-6893-7735","observed_orcids":["https://orcid.org/0000-0002-6893-7735"]},"institutions":[{"id":"https://openalex.org/I174878644","display_name":"University of Patras","ror":"https://ror.org/017wvtq80","country_code":"GR","type":"education","lineage":["https://openalex.org/I174878644"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Panagiotis Papathanasopoulos","raw_affiliation_strings":["Department of Neurology, Neuropsychology Section, University of Patras Medical School, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Neuropsychology Section, University of Patras Medical School, Greece","institution_ids":["https://openalex.org/I174878644"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5066152346"],"corresponding_institution_ids":["https://openalex.org/I174878644"],"apc_list":{"value":4030,"currency":"USD","value_usd":4030},"apc_paid":null,"fwci":3.3894,"has_fulltext":false,"cited_by_count":42,"citation_normalized_percentile":{"value":0.91355255,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"24","issue":"7","first_page":"524","last_page":"531"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/buprenorphine","display_name":"buprenorphine","score":0.968999981880188},{"id":"https://openalex.org/keywords/naltrexone","display_name":"naltrexone","score":0.9860000014305115},{"id":"https://openalex.org/keywords/heroin-dependence","display_name":"heroin addiction","score":0.7149999737739563},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.972000002861023},{"id":"https://openalex.org/keywords/cognitive-function","display_name":"cognitive function","score":0.6200000047683716},{"id":"https://openalex.org/keywords/neuropsychological-performance","display_name":"neuropsychological performance","score":0.8090000152587891},{"id":"https://openalex.org/keywords/methadone-maintenance-treatment","display_name":"methadone maintenance treatment","score":0.5770000219345093},{"id":"https://openalex.org/keywords/opioid-antagonists","display_name":"opioid antagonists","score":0.5879999995231628},{"id":"https://openalex.org/keywords/verbal-memory","display_name":"verbal memory","score":0.7170000076293945},{"id":"https://openalex.org/keywords/executive-function","display_name":"executive function","score":0.8709999918937683},{"id":"https://openalex.org/keywords/visual-perception","display_name":"visual perception","score":0.7480000257492065},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.4090000092983246}],"concepts":[{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.8133383393287659},{"id":"https://openalex.org/C2778903686","wikidata":"https://www.wikidata.org/wiki/Q60168","display_name":"Heroin","level":3,"score":0.7158191204071045},{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.6699652075767517},{"id":"https://openalex.org/C2778767360","wikidata":"https://www.wikidata.org/wiki/Q179996","display_name":"Methadone","level":2,"score":0.6552606225013733},{"id":"https://openalex.org/C14216870","wikidata":"https://www.wikidata.org/wiki/Q3872","display_name":"Neuropsychology","level":3,"score":0.5837721228599548},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5205557942390442},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.5073909163475037},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5063575506210327},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.4597378969192505},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.4487725794315338},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.4433958828449249},{"id":"https://openalex.org/C2780687700","wikidata":"https://www.wikidata.org/wiki/Q210978","display_name":"Abstinence","level":2,"score":0.42924198508262634},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4059072434902191},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3371170163154602},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1958245038986206},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.1273920238018036},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006556","descriptor_name":"Heroin Dependence","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D006556","descriptor_name":"Heroin Dependence","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006556","descriptor_name":"Heroin Dependence","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009483","descriptor_name":"Neuropsychological Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011597","descriptor_name":"Psychomotor Performance","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011939","descriptor_name":"Mental Recall","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014706","descriptor_name":"Verbal Learning","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1002/hup.1050","doi":"https://doi.org/10.1002/hup.1050","is_oa":false,"landing_page_url":"https://doi.org/10.1002/hup.1050","pdf_url":null,"source":{"id":"https://openalex.org/S154207414","display_name":"Human Psychopharmacology Clinical and Experimental","issn_l":"0885-6222","issn":["0885-6222","1099-1077"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Psychopharmacology: Clinical and Experimental","raw_type":"journal-article"},{"id":"pmid:19650155","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19650155","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human psychopharmacology","raw_type":"Clinical Trial"},{"id":"pmh:oai:dspace.lib.ntua.gr:123456789/28595","doi":null,"is_oa":true,"landing_page_url":"http://doi.org/10.1002/hup.1050","pdf_url":null,"source":{"id":"https://openalex.org/S4377196837","display_name":"DSpace - NTUA (National Technical University of Athens)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I174458059","host_organization_name":"National Technical University of Athens","host_organization_lineage":["https://openalex.org/I174458059"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Human Psychopharmacology-clinical and Experimental","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:dspace.lib.ntua.gr:123456789/28595","doi":null,"is_oa":true,"landing_page_url":"http://doi.org/10.1002/hup.1050","pdf_url":null,"source":{"id":"https://openalex.org/S4377196837","display_name":"DSpace - NTUA (National Technical University of Athens)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I174458059","host_organization_name":"National Technical University of Athens","host_organization_lineage":["https://openalex.org/I174458059"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Human Psychopharmacology-clinical and Experimental","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W1561944695","https://openalex.org/W1966724318","https://openalex.org/W1983132187","https://openalex.org/W1996188368","https://openalex.org/W2001379338","https://openalex.org/W2002129794","https://openalex.org/W2004823295","https://openalex.org/W2005071740","https://openalex.org/W2008291299","https://openalex.org/W2008292598","https://openalex.org/W2014162774","https://openalex.org/W2025950529","https://openalex.org/W2030933171","https://openalex.org/W2031161181","https://openalex.org/W2038583993","https://openalex.org/W2040327352","https://openalex.org/W2053094515","https://openalex.org/W2062139699","https://openalex.org/W2067278213","https://openalex.org/W2075334657","https://openalex.org/W2082883614","https://openalex.org/W2084785312","https://openalex.org/W2090734286","https://openalex.org/W2121767833","https://openalex.org/W2135891468","https://openalex.org/W2140341041","https://openalex.org/W2144884836","https://openalex.org/W2162105769","https://openalex.org/W2277974678","https://openalex.org/W4236082527","https://openalex.org/W4255396331"],"related_works":["https://openalex.org/W2025571890","https://openalex.org/W2115347065","https://openalex.org/W2007634967","https://openalex.org/W3033370734","https://openalex.org/W7100093057","https://openalex.org/W2003570136","https://openalex.org/W2107904472","https://openalex.org/W2053094515","https://openalex.org/W7161564749","https://openalex.org/W1252360520"],"abstract_inverted_index":{"RATIONALE:":[0],"Methadone":[1],"and":[2,55,76,101,112,119,139,147,217],"buprenorphine":[3,20],"are":[4,25,212],"among":[5],"the":[6,98,113,133,137,144,150,157,179],"most":[7],"widely":[8],"employed":[9],"pharmacological":[10],"treatments":[11],"currently":[12,46],"available":[13],"for":[14,214],"opioid":[15,221],"addiction.":[16],"Cognitive":[17],"effects":[18],"of":[19,34,44,70,73,80,104,122,132,153,182,202],"in":[21,130,178,193,199,220],"abstinent":[22,47,194],"heroin":[23,48,195],"abusers":[24,49,196],"nevertheless":[26],"far":[27],"from":[28,82],"being":[29],"understood.":[30],"METHODS:":[31],"Neuropsychological":[32],"performance":[33],"18":[35],"buprenorphine-maintained":[36],"patients":[37],"(BMP)":[38],"was":[39],"evaluated":[40],"relative":[41],"to":[42,163,206],"that":[43,165,189],"32":[45],"on":[50,97],"naltrexone":[51,192],"hydrochloride":[52],"therapy":[53],"(FHAN),":[54],"34":[56],"non-drug":[57],"dependent":[58],"controls.":[59,148],"The":[60,90],"three":[61],"groups":[62,67,141,160],"were":[63,126],"demographically":[64],"balanced.":[65],"Clinical":[66],"reported":[68],"histories":[69],"similar":[71],"patterns":[72],"drug":[74],"use":[75,86],"had":[77],"increased":[78],"periods":[79],"abstinence":[81],"any":[83,131],"illicit":[84],"substance":[85],"including":[87],"heroin.":[88],"RESULTS:":[89],"BMP":[91,138],"group":[92,146],"performed":[93],"poorer":[94],"than":[95],"controls":[96],"RAVLT":[99],"(encoding":[100],"delayed":[102,120],"recall":[103,121],"verbal":[105],"information),":[106],"CTT":[107],"(conceptual":[108],"flexibility,":[109],"executive":[110],"functions)":[111],"RBANS":[114],"figure":[115],"copy":[116],"(visual":[117],"perception)":[118],"visual":[123],"information.":[124],"There":[125],"no":[127],"significant":[128],"differences":[129,177],"cognitive":[134,180,203],"measures":[135],"between":[136,143,156],"FHAN":[140,145,171],"or":[142,170],"Furthermore,":[149],"non-differing":[151],"percentage":[152],"abnormal":[154],"cases":[155],"two":[158],"patient":[159],"led":[161],"us":[162],"infer":[164],"treatment":[166,190,207,218],"with":[167,191,208],"either":[168],"BPM":[169],"is":[172],"not":[173],"accompanied":[174],"by":[175],"qualitative":[176],"profiles":[181],"these":[183],"patients.":[184],"CONCLUSION:":[185],"Overall,":[186],"results":[187],"suggest":[188],"may":[197],"result":[198],"less":[200],"impairment":[201],"functions":[204],"compared":[205],"buprenorphine.":[209],"These":[210],"findings":[211],"relevant":[213],"improved":[215],"prognosis":[216],"strategies":[219],"dependence.":[222]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}